Circadian rest-activity rhythm disturbances in Alzheimer's disease. 1996

E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
Netherlands Institute for Brain Research, Amsterdam, The Netherlands.

Previous studies showed circadian rhythm disturbances in patients with Alzheimer's disease. Rest-activity rhythm disturbances manifest themselves through a fragmentation of the rhythm, a weak coupling with Zeitgebers, and high levels of activity during the night. The aim of the present study was to investigate which factors contribute to the presence of these disturbances. Therefore, several rest-activity rhythm, constitutional, and environmental variables were assessed in a heterogeneous group of 34 patients with Alzheimer's disease, including presenile and senile patients living at home or in a nursing home, as well as in 11 healthy controls. Circadian rest-activity rhythm disturbances were most prominent in institutionalized patients. Regression analyses showed the involvement of the following variables. First stability of the rest-activity rhythm is associated with high levels of daytime activity and high levels of environmental light resulting from seasonal effects as well as from indoor illumination. Presenile onset contributed to instability of the rhythm. Second, fragmentation of periods of activity and rest is associated with low levels of daytime activity, and is most prominent in moderately severe dementia. Third, night-time activity level is higher during the times of the year when the days are getting shorter and lower when the days are growing longer. These findings indicate that rest-activity rhythm disturbances may improve by increasing environmental light and daytime activity, an assumption for which empirical evidence has recently been published.

UI MeSH Term Description Entries
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
March 1990, Biological psychiatry,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
November 2020, Sleep,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
May 1997, Biological psychiatry,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
September 2010, International journal of Alzheimer's disease,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
January 2017, Chronobiology international,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
October 2006, The international journal of neuropsychopharmacology,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
January 1996, International psychogeriatrics,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
February 1997, Archives of general psychiatry,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
March 2003, La Revue de medecine interne,
E J van Someren, and E E Hagebeuk, and C Lijzenga, and P Scheltens, and S E de Rooij, and C Jonker, and A M Pot, and M Mirmiran, and D F Swaab
June 2018, Medical sciences (Basel, Switzerland),
Copied contents to your clipboard!